Financhill
Back

Evoke Pharma Stock Predictions

Evoke Pharma Stock Forecast

  • Is Evoke Pharma Stock Undervalued?
    The current Evoke Pharma [EVOK] share price is $4.33. The Score for EVOK is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
  • EVOK is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Evoke Pharma Stock Go Up Next Year?

Data Unavailable

Evoke Pharma Stock Rating

Data Unavailable

Evoke Pharma Stock Price History

Is EVOK stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVOK is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
evokepharma.com

52-Week Data

52-Week High:
17.40
52-Week Low:
3.54

Prediction Charts

Market Cap:
6.43M
Price in USD:
4.33
Volume:
36.41K
Beta:
0.60

Technical Analysis

SMA50:
5.13
SMA100:
5.26
SMA200:
5.95
52-Wk Change:
-71.24%

Stock Predictions

  • Is Evoke Pharma stock public?
    Yes, Evoke Pharma is a publicly traded company.
  • What is the Evoke Pharma stock quote today?
    The Evoke Pharma stock price is 4.33 USD today.
  • How to buy Evoke Pharma stock online?
    You can buy Evoke Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 5.58 5.79 6.09 5.31
Nov-6 5.90 5.84 6.02 5.64
Nov-7 5.67 5.65 5.98 5.56
Nov-8 5.87 5.70 5.91 5.54
Nov-11 5.59 5.38 5.69 5.30
Nov-12 5.30 5.00 5.50 4.90
Nov-13 4.80 4.30 5.02 4.03
Nov-14 4.29 4.37 4.59 4.29
Nov-15 4.40 4.58 4.58 4.37
Nov-18 4.58 4.37 4.65 4.35
Nov-19 4.28 4.70 4.79 4.28
Nov-20 4.70 4.56 4.70 4.50
Nov-21 4.58 4.50 4.60 4.50
Nov-22 4.50 4.33 4.60 4.33

Evoke Pharma Earnings

Data Unavailable

Evoke Pharma Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.78 per share, and an increase next year of $4.46 per share.

* Evoke Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.